knowledge -WSS

knowledge

author：explore 2025-10-02 09:47:24 - browse：35342

Stock exchange — Drew Angerer/Getty Images

Viking Therapeutics said Tuesday that its closely watched oral obesity drug had succeeded in an early-stage trial and that it planned to advance the medicine into the next phase of development.

The top-line results released Tuesday were only from a Phase 1 study, which primarily focuses on a drug’s safety. But Viking said that in the study, its medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues.

In preview notes, analysts had said that investors would want to see between 3% and 4% placebo-adjusted weight loss. Shares of San Diego-based Viking were up more than 20% in pre-market trading Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

WSS

Listen: Racing for gene therapy & a pioneering approval

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

White House drug shortage group privately met with industry

Baltimore teen accused of firing into crowd during block party mass shooting

Trump cancels press conference intended to dispute Georgia election interference charges

My superpower is killing ticks

Wikipedia

knowledge

focus

Wildfire smoke exposes gaps in outdoor worker protections

New definition of a human embryo proposed amid rapid advances

Anesthesiologist group: stop taking Ozempic before surgery

What Henrietta Lacks settlement says about racism in medicine

Anesthesiologist group: stop taking Ozempic before surgery

ActiGraph execs on goal of drug approvals with digital endpoints

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

White House drug shortage group privately met with industry

Peter Hotez and the public health issue of online harassment

Patient advocates sound warning on FDA proposal on salt intake

entertainment

FDA approves first treatment for ultra

Beware the threat of staffing cuts at the CDC

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Attacks on the drug industry will lead to fewer breakthroughs

Lung cancer is America's deadliest cancer. Yet so few get screened

OTC birth control: A brief history of over the counter pill design

knowledge

hotspot

knowledge

explore